Synthomer plc (LON:SYNT - Get Free Report)'s stock price rose 0.6% during mid-day trading on Monday . The company traded as high as GBX 175.63 ($2.24) and last traded at GBX 171 ($2.18). Approximately 163,101 shares changed hands during trading, a decline of 68% from the average daily volume of 513,549 shares. The stock had previously closed at GBX 170 ($2.17).
Analyst Ratings Changes
SYNT has been the topic of a number of analyst reports. Berenberg Bank reduced their price target on Synthomer from GBX 375 ($4.79) to GBX 340 ($4.34) and set a "buy" rating on the stock in a research report on Tuesday, August 13th. Canaccord Genuity Group reduced their price target on Synthomer from GBX 300 ($3.83) to GBX 275 ($3.51) and set a "buy" rating on the stock in a research report on Friday, October 4th.
Get Our Latest Analysis on Synthomer
Synthomer Stock Performance
The firm has a market capitalization of £276.11 million, a P/E ratio of -276.72, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 77.42. The company has a 50-day moving average of GBX 177.75 and a 200-day moving average of GBX 228.08.
About Synthomer
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Recommended Stories
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.